Coronavirus information from UCLA and UCLA Health.

ElectroNucleics is developing a fast, inexpensive and highly sensitive means to detect the presence of pathogens in fluids.

ElectroNucleics is developing a low-cost, robust, point-of-care molecular diagnostic device that gives results in mere minutes. There is an urgent need for pathogen detection that gives fast results so that patients suffering from influenza, gonorrhea, etc. can be diagnosed and treated during the same clinical visit. Their optics-free device output gives a highly selective, binary response signaling the presence or absence of the target nucleic acid. Its cost, ease of use, and rapid response give it critical advantages over conventional nucleic acid detection technologies, for which there are no CLIA-waived tests for gonorrhea, a CDC top-three public health threat.

Graduated: 2021
Location: Placentia, CA

Contact: electronucleics.com/contact-us